STAAR Surgical Company Total Assets
STAAR Surgical Company total assets. Based on the latest financial reports, STAAR Surgical Company (STAA) holds total assets worth $475.20 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see STAA market cap overview for the company's overall valuation and market capitalisation.
Total Assets of STAAR Surgical Company (1988–2025)
Total assets of STAAR Surgical Company from 1988 to 2025. This chart illustrates how STAAR Surgical Company's total assets have evolved over time, based on quarterly financial data. See STAA share price today for real-time trading data and today's change.
STAAR Surgical Company - Asset Composition Analysis
STAAR Surgical Company Total Assets Breakdown (December 2025)
STAAR Surgical Company total assets breakdown as of December 2025. STAAR Surgical Company's total assets of $475.20 Million consist of 67.5% current assets and 32.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 33.2% |
| Accounts Receivable | $54.61 Million | 11.8% |
| Inventory | $55.50 Million | 12.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $30.70 Million | 6.7% |
| Goodwill | $1.79 Million | 0.4% |
Asset Composition Trend (1988–2025)
This chart illustrates how STAAR Surgical Company's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore STAAR Surgical Company working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: STAAR Surgical Company's current assets represent 67.5% of total assets in 2025, an increase from 38.5% in 1988.
- Cash Position: Cash and equivalents constituted 33.2% of total assets in 2025, up from 0.6% in 1988.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 0.0% in 1988.
- Asset Diversification: The largest asset category is inventory at 12.0% of total assets.
STAAR Surgical Company Competitors by Total Assets
Key competitors of STAAR Surgical Company based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Caina Technology Co. Ltd.
SHE:301122
|
China | CN¥2.26 Billion |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Nyxoah
BR:NYXH
|
Belgium | €93.60 Million |
|
Ocumetics Technology Corp
V:OTC
|
Canada | CA$1.15 Million |
|
Osteopore Ltd
AU:OSX
|
Australia | AU$2.77 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.39 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
STAAR Surgical Company - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.66 | 4.94 | 5.64 |
| Quick Ratio | 4.03 | 4.05 | 5.29 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $268.96 Million | $233.56 Million | $217.15 Million |
STAAR Surgical Company - Advanced Valuation Insights
This section examines the relationship between STAAR Surgical Company's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.55 |
| Latest Market Cap to Assets Ratio | 2.71 |
| Asset Growth Rate (YoY) | -9.4% |
| Total Assets | $461.62 Million |
| Market Capitalization | $1.25 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values STAAR Surgical Company's assets at a significant premium (2.71x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: STAAR Surgical Company's assets decreased by 9.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for STAAR Surgical Company (1988–2025)
The table below shows the annual total assets of STAAR Surgical Company from 1988 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $461.62 Million | -9.40% |
| 2024-12-31 | $509.52 Million | +4.26% |
| 2023-12-31 | $488.69 Million | +16.68% |
| 2022-12-31 | $418.82 Million | +21.12% |
| 2021-12-31 | $345.78 Million | +34.33% |
| 2020-12-31 | $257.42 Million | +24.04% |
| 2019-12-31 | $207.52 Million | +24.01% |
| 2018-12-31 | $167.34 Million | +146.33% |
| 2017-12-31 | $67.93 Million | +3.80% |
| 2016-12-31 | $65.44 Million | +3.95% |
| 2015-12-31 | $62.95 Million | +6.86% |
| 2014-12-31 | $58.91 Million | -4.88% |
| 2013-12-31 | $61.93 Million | +13.10% |
| 2012-12-31 | $54.76 Million | +11.74% |
| 2011-12-31 | $49.01 Million | +20.75% |
| 2010-12-31 | $40.59 Million | -30.84% |
| 2009-12-31 | $58.68 Million | +11.60% |
| 2008-12-31 | $52.58 Million | -2.95% |
| 2007-12-31 | $54.18 Million | +13.42% |
| 2006-12-31 | $47.77 Million | -9.45% |
| 2005-12-31 | $52.76 Million | +1.50% |
| 2004-12-31 | $51.97 Million | +10.07% |
| 2003-12-31 | $47.22 Million | +4.42% |
| 2002-12-31 | $45.22 Million | -31.28% |
| 2001-12-31 | $65.81 Million | -17.90% |
| 2000-12-31 | $80.15 Million | -6.03% |
| 1999-12-31 | $85.30 Million | +16.37% |
| 1998-12-31 | $73.30 Million | +17.47% |
| 1997-12-31 | $62.40 Million | +22.11% |
| 1996-12-31 | $51.10 Million | +31.70% |
| 1995-12-31 | $38.80 Million | +34.26% |
| 1994-12-31 | $28.90 Million | +53.72% |
| 1993-12-31 | $18.80 Million | +46.88% |
| 1992-12-31 | $12.80 Million | +36.17% |
| 1991-12-31 | $9.40 Million | -11.32% |
| 1990-12-31 | $10.60 Million | -20.30% |
| 1989-12-31 | $13.30 Million | -17.39% |
| 1988-12-31 | $16.10 Million | -- |
About STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorde… Read more